Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Saga Continues for St. Christopher’s Hospital for Children
Where there’s a hospital or health system filing for bankruptcy protection, there’s usually a sale in the offing that involves a real estate investment trust. That’s the most recent twist in the story of St. Christopher’s Hospital for Children, which we first reported in September 2019. The 188-bed hospital, a critical safety-net hospital for children in North Philadelphia, and Hahnemann University Hospital were sold in September 2018 to California investment banker Joel Freedman, head of American Academic Health System, LLC (AAHS), for $170 million. Hahnemann’s financial troubles prompted Freedman to file for Chapter 11 bankruptcy protection for both hospitals on... Read More »
Quest Acquires Memorial Hermann Outreach Labs
Quest Diagnostics (NYSE: DGX) has had a busy month. On January 22, it acquired Blueprint Genetics, a leading genetic testing company based in Helsinki, Finland, for an undisclosed amount. Now, it’s turned its sites back home. On January 27, it announced a deal for substantially all of the Memorial Hermann Diagnostic Laboratories (MDHL), the outreach lab division of not-for-profit Memorial Hermann Health System in Houston. Memorial Hermann has 17 hospitals and more than 300 care delivery sites in the greater Houston area. The acquisition includes nearly 30 MHDL patient service centers and nearly 60 in-office laboratory service sites. These services will transition to the Quest... Read More »
Health Care M&A Deals, Week Ending January 31, 2020
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price AstraZeneca plc Global rights to brazikumab N/A Home Health Care & Hospice Acquirer Target Price Eden Health Legacy Home Healthcare N/A Pharmaceuticals Acquirer Target Price Nestle SA Zenpep and Viokace N/A Atnahs Pharma Rights to hypertension... Read More »
PE-Backed Phoenix Rehabilitation Adds New Clinic
Phoenix Rehabilitation and Health Services Inc. has been on an acquisition spree since Audax Group acquired the group in December 2018. The rehabilitation firm has reported three deals since then, growing at a steady pace across the country. The partnership first reported a deal last September, acquiring Black Mountain Physical Therapy in Black Mountain, North Carolina. Black Mountain offers a range of treatment including skilled manual therapies, therapeutic exercises, and neuromuscular reeducation to treat biomechanical and structural problems. The clinic gave Phoenix a foothold in the North Carolina market. Just before the end of 2019, Phoenix acquired a physical therapy clinic in in... Read More »
A Good Start for Biotech in 2020
Early in January 2019, Bristol-Myers Squibb’s (NYSE: BMY) $74 billion acquisition of Celgene Corporation dominated the headlines. But despite that big deal, 2019 was a rather lackluster year for the Biotechnology sector. However, the opening quarter of 2020 is showing some promise. This year’s J.P. Morgan Healthcare Conference came and went without any major announcements, but the Biotech sector is seeing a steady start, with a modest $930 million in spending with 11 announced transactions. A bulk of that dollar volume came from Incyte Corporation’s (NASDAQ: INCY) deal with MorphoSys AG (NASDAQ: MOR) for tafasitamab. The collaboration and license agreement aim to further... Read More »
Quest Diagnostics Buys Genetic Testing Company
Quest Diagnostics (NYSE: DGX) broadened its scope in genetics and rare diseases with the January 22 acquisition of Blueprint Genetics, based in Helsinki, Finland. Founded in 2012, the target now serves customers in more than 70 countries. Financial terms of the all-cash equity transaction were not disclosed. Blueprint is a leading specialty genetic testing company with deep expertise in gene variant interpretation based on next generation sequencing (NGS) and proprietary bioinformatics. It provides 3,900 targeted single gene and more than 200 panel tests spanning 14 medical specialties. Its growth comes largely from its proprietary guideline-supported methods of gene variant interpretation... Read More »
Summit BHC Moves into Colorado
It’s been some time since we heard about Summit BHC. There’s a good reason, too. It hasn’t announced an acquisition since October 2018. Now comes news the firm has moved into Colorado, making its first acquisition in the state. On January 22, the company added Peak View Behavioral Health, a 112-bed acute psychiatric and behavioral health hospital in Colorado Springs. Financial terms were not disclosed. Summit was founded in 2013 to develop and operate a network of addiction treatment and behavioral health centers throughout the United States. Flexpoint Ford LLC made a controlling investment in the Franklin, Tennessee-based firm in 2015 and exited in October 2017 to Lee... Read More »
Ensign Group Spin-Off Makes Another Deal
In October 2019, The Ensign Group (NASDAQ: ENSG) and The Pennant Group, Inc. (NASDAQ: PNTG) announced the completion of Pennant’s spin-off. The two separated to give investors more and better industry-specific options; The Ensign Group will stay focused on services ranging from skilled nursing to various forms of therapy and rehab, while The Pennant Group will operate in the home health and hospice and senior living markets. The latter is comprised of two of Ensign’s former subsidiaries, Cornerstone Health and Pinnacle Senior Living. And now in early 2020, The Pennant Group is keeping its promise and wasting no time to expand. In early January, Cornerstone Healthcare acquired... Read More »Hospital M&A Outlook
The Hospital sector ended 2019 with 80 transactions in the United States reaching the definitive agreement stage or closing. All told, 99 hospital deals are on the books for the year, which is a 25% increase over 2018’s 79 hospital deals. For the fourth quarter of 2019, 23 transactions reached the definitive agreement stage or closing. That was a 21% decline from the third quarter’s 29 deals, but a 10% gain over the same quarter in 2018. What’s ahead for the Hospital sector in 2020? More of the same, meaning that consolidation among strong regional health systems will continue the trend that began a few years ago. Small standalone hospitals will still push to join a... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
